These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30686792)

  • 21. 1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
    Karabanovich G; Roh J; Smutný T; Němeček J; Vicherek P; Stolaříková J; Vejsová M; Dufková I; Vávrová K; Pávek P; Klimešová V; Hrabálek A
    Eur J Med Chem; 2014 Jul; 82():324-40. PubMed ID: 24927053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and identification of β-aryloxyquinoline based diversely fluorine substituted N-aryl quinolone derivatives as a new class of antimicrobial, antituberculosis and antioxidant agents.
    Kathrotiya HG; Patel MP
    Eur J Med Chem; 2013 May; 63():675-84. PubMed ID: 23567957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. meso-Dihydroguaiaretic acid derivatives with antibacterial and antimycobacterial activity.
    Reyes-Melo K; García A; Romo-Mancillas A; Garza-González E; Rivas-Galindo VM; Miranda LD; Vargas-Villarreal J; Favela-Hernández JMJ; Camacho-Corona MDR
    Bioorg Med Chem; 2017 Oct; 25(20):5247-5259. PubMed ID: 28844400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds.
    Krátký M; Janďourek O; Baranyai Z; Novotná E; Stolaříková J; Bősze S; Vinšová J
    Eur J Med Chem; 2019 Nov; 181():111578. PubMed ID: 31401536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of novel pleuromutilin derivatives. Part 1: preliminary studies of antituberculosis activity.
    Dong YJ; Meng ZH; Mi YQ; Zhang C; Cui ZH; Wang P; Xu ZB
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1799-1803. PubMed ID: 25736994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploiting the furo[2,3-b]pyridine core against multidrug-resistant Mycobacterium tuberculosis.
    Fumagalli F; de Melo SMG; Ribeiro CM; Solcia MC; Pavan FR; da Silva Emery F
    Bioorg Med Chem Lett; 2019 Apr; 29(8):974-977. PubMed ID: 30803803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of 11α-substituted bile acid derivatives as potential anti-tuberculosis agents.
    Pore VS; Divse JM; Charolkar CR; Nawale LU; Khedkar VM; Sarkar D
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4185-90. PubMed ID: 26299346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design.
    Pieroni M; Wan B; Zuliani V; Franzblau SG; Costantino G; Rivara M
    Eur J Med Chem; 2015 Jul; 100():44-9. PubMed ID: 26071857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, Antibacterial and Antitubercular Activities of Some 5H-Thiazolo[3,2-a]pyrimidin-5-ones and Sulfonic Acid Derivatives.
    Cai D; Zhang ZH; Chen Y; Yan XJ; Zou LJ; Wang YX; Liu XQ
    Molecules; 2015 Sep; 20(9):16419-34. PubMed ID: 26378507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and In vitro antituberculosis activity of 2(5H)-Furanone derivatives.
    Ngwane AH; Panayides JL; Chouteau F; Macingwana L; Viljoen A; Baker B; Madikane E; de Kock C; Wiesner L; Chibale K; Parkinson CJ; Mmutlane EM; van Helden P; Wiid I
    IUBMB Life; 2016 Aug; 68(8):612-20. PubMed ID: 27346745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conjugation of a 5-nitrofuran-2-oyl moiety to aminoalkylimidazoles produces non-toxic nitrofurans that are efficacious in vitro and in vivo against multidrug-resistant Mycobacterium tuberculosis.
    Krasavin M; Lukin A; Vedekhina T; Manicheva O; Dogonadze M; Vinogradova T; Zabolotnykh N; Rogacheva E; Kraeva L; Yablonsky P
    Eur J Med Chem; 2018 Sep; 157():1115-1126. PubMed ID: 30179748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and antimycobacterial activity of novel camphane-based agents.
    Stavrakov G; Philipova I; Valcheva V; Momekov G
    Bioorg Med Chem Lett; 2014 Jan; 24(1):165-7. PubMed ID: 24332625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and antibacterial evaluation of macrocyclic diarylheptanoid derivatives.
    Lin H; Bruhn DF; Maddox MM; Singh AP; Lee RE; Sun D
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4070-6. PubMed ID: 27406794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, identification and in vitro biological evaluation of some novel quinoline incorporated 1,3-thiazinan-4-one derivatives.
    Umamatheswari S; Sankar C
    Bioorg Med Chem Lett; 2017 Feb; 27(3):695-699. PubMed ID: 28065567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis.
    Karabanovich G; Zemanová J; Smutný T; Székely R; Šarkan M; Centárová I; Vocat A; Pávková I; Čonka P; Němeček J; Stolaříková J; Vejsová M; Vávrová K; Klimešová V; Hrabálek A; Pávek P; Cole ST; Mikušová K; Roh J
    J Med Chem; 2016 Mar; 59(6):2362-80. PubMed ID: 26948407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of new 1,3,5-triazine scaffolds with potent activity against Mycobacterium tuberculosis H37Rv.
    Sunduru N; Gupta L; Chaturvedi V; Dwivedi R; Sinha S; Chauhan PM
    Eur J Med Chem; 2010 Aug; 45(8):3335-45. PubMed ID: 20452706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines.
    Tonelli M; Novelli F; Tasso B; Sparatore A; Boido V; Sparatore F; Cannas S; Molicotti P; Zanetti S; Parapini S; Loddo R
    Bioorg Med Chem; 2014 Dec; 22(24):6837-45. PubMed ID: 25464882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis.
    Shakya N; Srivastav NC; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2010 May; 53(10):4130-40. PubMed ID: 20420370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, biological evaluation, structure-activity relationship, and toxicity of clinafloxacin-azole conjugates as novel antitubercular agents.
    Liu J; Ren Z; Fan L; Wei J; Tang X; Xu X; Yang D
    Bioorg Med Chem; 2019 Jan; 27(1):175-187. PubMed ID: 30522898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.
    Matviiuk T; Rodriguez F; Saffon N; Mallet-Ladeira S; Gorichko M; de Jesus Lopes Ribeiro AL; Pasca MR; Lherbet C; Voitenko Z; Baltas M
    Eur J Med Chem; 2013; 70():37-48. PubMed ID: 24140915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.